NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 8/31/2022 | 5/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $4 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $1 | $5 | $3 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.75 | -0.063 | -0.84 | -0.83 |
| % Growth | -7,487.9% | 92.5% | -1.2% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$1 |